Xilio Development Kurtosis

XLO Stock  USD 8.31  -0.16  -1.89%   
Kurtosis is a measure of the return distribution. In a similar way to the concept of skewness, kurtosis is a descriptor of the shape of a return distribution. There are various interpretations of kurtosis, and of how particular measures should be interpreted; these are primarily peakedness (width of peak), tail weight, and lack of shoulders (distribution primarily peak and tails, not in between). Below is Xilio Development's current Kurtosis with peer comparisons and related risk metrics.

Current Kurtosis Value

At 2.38, Xilio Development's Kurtosis indicates thin tails relative to a normal distribution. Xilio Development's returns cluster closer to the mean with fewer extreme moves than a normal distribution.

Kurtosis

 = 

4PM

STD4

 = 
2.38
4PM = Forth upper moment
STD =   Standard Deviation of Xilio Development

Kurtosis Peers Comparison

Among sector peers, Xilio Development's Kurtosis of 2.38 is below the 6.01 group average. The range runs from -0.0953 (Tvardi Therapeutics) to 29.3 (Kezar Life Sciences).

Kurtosis Relative To Other Indicators

The chart below plots Kurtosis against Maximum Drawdown for Xilio Development and its peers. Each point represents one equity — position along the horizontal axis shows Kurtosis while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Xilio Development shows nearly 7.05 of Maximum Drawdown per unit of Kurtosis ( 2.38 versus 16.77 ). This indicates Maximum Drawdown substantially exceeds Kurtosis for Xilio Development.
Compare Xilio Development to Peers

Methodology, Assumptions & Data Sources

Xilio Development's Kurtosis currently stands at 2.38. The Kurtosis for Xilio Development is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Xilio Development operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Values are specific to the selected time horizon and may differ across measurement periods. This indicator does not constitute investment advice.

Other Technical Indicators